Primary unilateral macronodular adrenal hyperplasia with concomitant glucocorticoid and androgen excess and KDM1A inactivation.
Saved in:
| Title: | Primary unilateral macronodular adrenal hyperplasia with concomitant glucocorticoid and androgen excess and KDM1A inactivation. |
|---|---|
| Authors: | Elhassan YS; Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, United Kingdom.; Centre for Endocrinology, Diabetes and Metabolism, University Hospitals Birmingham NHS Foundation Trust, Birmingham Health Partners, Birmingham, United Kingdom., Appenzeller S; Comprehensive Cancer Center Mainfranken, University of Würzburg, Würzburg, Germany., Landwehr LS; Division of Endocrinology and Diabetes, Department of Internal Medicine I, University Hospital, University of Würzburg, Würzburg, Germany., Lippert J; Division of Endocrinology and Diabetes, Department of Internal Medicine I, University Hospital, University of Würzburg, Würzburg, Germany., Popat D; Faculty of Medicine and Dentistry, Centre for Endocrinology, William Harvey Research Institute, Queen Mary University of London, London, United Kingdom., Gilligan LC; Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, United Kingdom., Abdi L; MRC Laboratory of Medical Sciences, London, United Kingdom., Goh E; Birmingham Women's Hospital, Birmingham, United Kingdom., Diaz-Cano S; Department of Pathology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom., Kircher S; Department of Pathology, University of Würzburg, Würzburg, Germany., Gramlich S; Department of Pathology, University of Würzburg, Würzburg, Germany., Sutcliffe RP; The Liver Unit, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom., Thangaratinam S; Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, United Kingdom.; Birmingham Women's Hospital, Birmingham, United Kingdom.; NIHR Birmingham Biomedical Research Centre, University Hospitals Birmingham NHS Foundation Trust and University of Birmingham, Birmingham, United Kingdom., Chan LF; Faculty of Medicine and Dentistry, Centre for Endocrinology, William Harvey Research Institute, Queen Mary University of London, London, United Kingdom., Fassnacht M; Comprehensive Cancer Center Mainfranken, University of Würzburg, Würzburg, Germany.; Division of Endocrinology and Diabetes, Department of Internal Medicine I, University Hospital, University of Würzburg, Würzburg, Germany., Arlt W; Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, United Kingdom.; MRC Laboratory of Medical Sciences, London, United Kingdom.; Faculty of Medicine, Institute of Clinical Sciences, Imperial College London, London, United Kingdom., Ronchi CL; Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, United Kingdom.; Centre for Endocrinology, Diabetes and Metabolism, University Hospitals Birmingham NHS Foundation Trust, Birmingham Health Partners, Birmingham, United Kingdom. |
| Source: | European journal of endocrinology [Eur J Endocrinol] 2024 Aug 30; Vol. 191 (3), pp. 334-344. |
| Publication Type: | Journal Article; Case Reports |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 9423848 Publication Model: Print Cited Medium: Internet ISSN: 1479-683X (Electronic) Linking ISSN: 08044643 NLM ISO Abbreviation: Eur J Endocrinol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1479-683X |
|---|---|
| DOI: | 10.1093/ejendo/lvae106 |
